Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2680351000168119 | Olmesart HCT 20/12.5 (GxP) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
2680361000168117 | Olmesart HCT 20/12.5 (GxP) tablet, 10 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Olmesart HCT 20/12.5 (GxP) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets (trade product pack) | Is a | trade product pack | true | Inferred relationship | Some | ||
Olmesart HCT 20/12.5 (GxP) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets (trade product pack) | Is a | hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg tablet, 10 tablets (medicinal product pack) | true | Inferred relationship | Some | ||
Olmesart HCT 20/12.5 (GxP) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets (trade product pack) | has TPUU | Olmesart HCT 20/12.5 (GxP) tablet | true | Inferred relationship | Some | 1 | |
Olmesart HCT 20/12.5 (GxP) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets (trade product pack) | has TP | Olmesart HCT 20/12.5 (GxP) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Olmesart HCT 20/12.5 (GxP) tablet, 10, blister pack | Is a | True | Olmesart HCT 20/12.5 (GxP) (hydrochlorothiazide 12.5 mg + olmesartan medoxomil 20 mg) tablet, 10 tablets (trade product pack) | Inferred relationship | Some |
Reference Sets
Trade product pack reference set